Lindstrom Richard L MD
- SEC CIK
- 0001242177
In the past year, 1 open-market purchase filing worth $461.4K and no sales.
Current role at each company
- OCUL Ocular Therapeutix, IncDirectoras of Jun 12, 2026
- LNSR LENSAR, Inc.Directoras of Jun 5, 2026
- HROW Harrow, Inc.Directoras of Oct 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $461.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$461.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lindstrom Richard L MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OCUL Ocular Therapeutix, Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 (view filing) | Feb 20 | 4 days | Lindstrom Richard L MDDirector | PPurchase | +60.2K | $7.66 | +$461.4K | +32.3%246.9K after | |
| May 12, 2025 (view filing) | May 8 | 4 days | Lindstrom Richard L MDDirector | PPurchase | +10.0K | $6.96 | +$69.6K | +6.1%172.7K after |
HROW Harrow, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 (view filing) | Sep 30 | 3 days | Lindstrom Richard L MDDirector | SSale | −40.0K | $12.62 | −$504.8K | −60.5%26.1K after | |
| Sep 27, 2021 (view filing) | Sep 24 | 3 days | Lindstrom Richard L MDDirector | SSale | −3.90K | $10.04 | −$39.2K | −5.6%66.1K after | |
| Sep 17, 2021 (view filing) | Sep 15-16 | 2 days | Lindstrom Richard L MDDirector | SSale | −20.0K | $9.07 | −$181.4K | −22.2%70.0K after | 2 lots |